4//SEC Filing
Yu John S 4
Accession 0001493152-25-025197
CIK 0001962011other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 5:24 PM ET
Size
5.7 KB
Accession
0001493152-25-025197
Insider Transaction Report
Form 4
Yu John S
DirectorCEO and Chairman10% Owner
Transactions
- Award
COMMON STOCK
2025-10-08+190,840→ 230,105 total
Holdings
- 5,316,572(indirect: By Trust)
COMMON STOCK
Footnotes (2)
- [F1]Represents 190,840 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 190,840 RSUs are scheduled to vest in full on the first anniversary of the grant date.
- [F2]Consists of (1) 34,599 shares of common stock (2) 195,506 RSUs which remain subject to vesting.
Documents
Issuer
Kairos Pharma, LTD.
CIK 0001962011
Entity typeother
Related Parties
1- filerCIK 0001550545
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 5:24 PM ET
- Size
- 5.7 KB